CRSP 8-K 2026-08-03

CRISPR Therapeutics AG (CRSP) 8-K dated 2026-08-03 — accession 0001193125-26-330644.

CRISPR Therapeutics AG (CRSP) is a biotechnology company listed on US.

CRISPR Therapeutics AG filed a 8-K on 2026-08-03. Accession 0001193125-26-330644.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CRSP revenue for 2025-12-31 was $3.5M. Net income was -$581.6M. Revenue was down 90.6% from 2024-12-31 to 2025-12-31. CRSP currently screens at market cap $5.42B.

Not investment advice. The CRSP SEC hub lists recent forms. The stock page is the research view.